Managing crohn's disease in adults: a summary of the guidelines
Boudreau R, Spry C
Record ID 32011001286
English
Authors' recommendations:
Treating CD is a complex endeavor. Recent American and European guidelines provide insight into various treatment strategies that can be used. The guidelines contained within the appendices provide information on the evidence level with which recommendations are based, thus clarifying which treatment options are based on more or less rigorous evidence and which guidelines are based on expert opinions. However, the treatment guidelines may not be appropriate for all patients. There are abundant pharmaceutical therapies that can be used for various stages, locations, and severities of CD. It is not plausible to indicate what the common first-line, second-line, and third-line treatments should be used for CD, as it is a complex disease and treatment depends on each patient’s situation. Knowledge of the patient’s history, as well as the patient’s opinion and circumstances, should be considered by clinician’s when deciding how to best manage active CD or maintain remission.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.cadth.ca/media/pdf/htis/L0080%20Managing%20Crohn's%20Disease%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Practice Guidelines as Topic
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.